Moderna | Coinspeaker

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.

Click to see more

Moderna News

Editor's Choice, Markets, Stocks MRNA Stock 11.90% Up, Moderna Plans to Begin COVID-19 Vaccine Human Trials This Spring

By Daria Rud April 3rd, 2020

According to Moderna Chairman Noubar Afeyan, the second phase of human trials of the COVID-19 vaccine might begin this spring. If the testing is successful, the 3rd phase will immediately begin. MRNA stock went up.

Markets, News, Stocks JNJ, MRNA Stocks Down Around 1.5%, J&J and Moderna to Produce Possible COVID-19 Vaccine

By CoinSpeaker Staff March 31st, 2020

The U.S government has partnered Johnson & Johnson and Moderna to facilitate the production of the possible COVID-19 vaccine in large quantities.

Business, Editor's Choice, Markets, News, Stocks Abbott Laboratories (ABT) Stock Rose 8% in Pre-Market Trading and Is Up 6.83% Now

By Daria Rud March 30th, 2020

Abbott Laboratories (ABT) stock rises further following the company’s announcement about its system for identifying coronavirus. Today, during the pre-market hours, Abbott Laboratories shares were 8.77% up. Now they are 6.83% up.